101 hits for »HTA «
…Progress towards a holistic, viable solution requires all key parties in the healthcare ecosystem to join the dialogue. What are the major health policy issues and themes that you focused most on in 2022 and focusing on in 2023? The EU HTA Regulation is a…
…access? Registration & Episode Details Episode Two – 6 July (16:00 – 17:00 CET) Defining (H)UMN: will it steer innovation towards filling existing gaps? Registration & Episode Details Episode Three – 7 September (16:00 – 17:00 CET) EU HTA Regulation: How will the revised Pharma…
…OMP Regulation by focusing on modulation of market exclusivity, and we will officially launch our proposals for an EU HTA methodology for OMPs. Join us for an event that brings together a diverse group of rare disease experts to discuss and propose policy recommendations for…
…industrial investment, flexible and tailored regulatory and HTA approaches, massive data collection and reuse for research and development from the ERNs and the healthcare system in general” “Demonstrating something that is beyond significant benefit and potentially even beyond the therapeutic relevance, which is already tested…
…DATE Don’t miss out on the third episode of the Life Science Lectures on “EU HTA: How will the Pharmaceutical Package impact value assessment of therapies?”’ scheduled for 7 September 2023. Save the date and register now to secure your spot. Stay tuned for updates…
…to cancer care. Discussions will focus on the personal—what will the interventions and initiatives featured in these sessions mean for people in Europe? EUCOPE’s Alexander Natz will speak on 21 September in the panel: The impact of European Health Technology Assessment (HTA) regulation Register here…
…key topics such as the EU Pharmaceutical Legislation, Clinical Trial Regulation and EU HTA Regulation to partner and drive advocacy efforts. We look forward to working closely with EUCOPE in identifying opportunities, such as this Member Spotlight, to share Dyne’s efforts in working to help…
The world-leading healthcare evidence, pricing, and access congress is taking place in Amsterdam in 2024. The main topics that will be covered during the event are the following: Market Access, Rare Diseases, Evidence, Pricing, Emerging Markets, HTA/Payers, Advanced Therapies, Health Economics & Outcomes Research, Patient…
…Gottlieb, Former Commissioner, U.S. Food and Drug Administration, who will be leading the debate on future-proofing pharmaceutical legislation from a global perspective. The program will also include representatives from the European Commission (DG COMP and Legal Service), the EMA (HTA), investors, and various industry leaders….
The World Evidence, Pricing and Access Congress is Europe’s largest congress in market access, pricing and evidence featuring 300 speakers, multiple streams and over 1200 attendees from pharma, biotech and Payers/HTA’s. Join in Amsterdam for 2025! See here the agenda and speakers….
You are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information